121 related articles for article (PubMed ID: 38616116)
1. Sustained Release Formulation of Hydroxypropyl-β-cyclodextrin Eye Drops Using Xanthan Gum.
Higashi T; Goto T; Onodera R; Hirotsu T; Ikeda HO; Motoyama K
Chem Pharm Bull (Tokyo); 2024; 72(4):381-384. PubMed ID: 38616116
[TBL] [Abstract][Full Text] [Related]
2. Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes.
Hata M; Ikeda HO; Iwai S; Iida Y; Gotoh N; Asaka I; Ikeda K; Isobe Y; Hori A; Nakagawa S; Yamato S; Arita M; Yoshimura N; Tsujikawa A
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3936-3941. PubMed ID: 29581279
[TBL] [Abstract][Full Text] [Related]
3. Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.
Kubota Y; Hoshiko T; Higashi T; Motoyama K; Okada S; Kimura S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069042
[TBL] [Abstract][Full Text] [Related]
4. 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.
Yokoo M; Kubota Y; Motoyama K; Higashi T; Taniyoshi M; Tokumaru H; Nishiyama R; Tabe Y; Mochinaga S; Sato A; Sueoka-Aragane N; Sueoka E; Arima H; Irie T; Kimura S
PLoS One; 2015; 10(11):e0141946. PubMed ID: 26535909
[TBL] [Abstract][Full Text] [Related]
5. PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy.
Zhang Z; Yan B; Gao F; Li Q; Meng X; Chen P; Zhou L; Deng W; Li C; Xu W; Han S; Feng H; Li Y; Chen J; Yin Z; Liao C; Tse HF; Xu A; Lian Q
Mol Ther; 2020 Dec; 28(12):2642-2661. PubMed ID: 32755565
[TBL] [Abstract][Full Text] [Related]
6. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268
[TBL] [Abstract][Full Text] [Related]
7. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
8. Metronidazole/Hydroxypropyl-β-Cyclodextrin inclusion complex nanofibrous webs as fast-dissolving oral drug delivery system.
Celebioglu A; Uyar T
Int J Pharm; 2019 Dec; 572():118828. PubMed ID: 31715341
[TBL] [Abstract][Full Text] [Related]
9. Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.
Malhotra S; Khare A; Grover K; Singh I; Pawar P
J Pharm (Cairo); 2014; 2014():490595. PubMed ID: 26556196
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation.
Matassoli FL; Leão IC; Bezerra BB; Pollard RB; Lütjohann D; Hildreth JEK; Arruda LB
mSphere; 2018 Nov; 3(6):. PubMed ID: 30404938
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives.
Ikeda Y; Kimura K; Hirayama F; Arima H; Uekama K
J Control Release; 2000 May; 66(2-3):271-80. PubMed ID: 10742586
[TBL] [Abstract][Full Text] [Related]
12. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
Gohel MC; Amin AF; Patel KV; Panchal MK
Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
[TBL] [Abstract][Full Text] [Related]
13. In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease.
Maeda Y; Motoyama K; Nishiyama R; Higashi T; Onodera R; Nakamura H; Takeo T; Nakagata N; Yamada Y; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
Nanomaterials (Basel); 2019 May; 9(5):. PubMed ID: 31130658
[TBL] [Abstract][Full Text] [Related]
14. Influence of hydroxypropyl beta-cyclodextrin on the stability of benzylpenicillin in chloroacetate buffer.
Ong JK; Sunderland VB; McDonald C
J Pharm Pharmacol; 1997 Jun; 49(6):617-21. PubMed ID: 9330202
[TBL] [Abstract][Full Text] [Related]
15. Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines.
Bezerra BB; Silva GPDD; Coelho SVA; Correa IA; Souza MRM; Macedo KVG; Matos BM; Tanuri A; Matassoli FL; Costa LJD; Hildreth JEK; Arruda LB
Antiviral Res; 2022 Sep; 205():105373. PubMed ID: 35798224
[TBL] [Abstract][Full Text] [Related]
16. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Eur J Pharm Sci; 1998 Jan; 6(1):53-9. PubMed ID: 16256708
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-Lowering Effect of Octaarginine-Appended β-Cyclodextrin in Npc1-Trap-CHO Cells.
Motoyama K; Nishiyama R; Maeda Y; Higashi T; Kawaguchi Y; Futaki S; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
Biol Pharm Bull; 2016 Nov; 39(11):1823-1829. PubMed ID: 27601082
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
Celebioglu A; Uyar T
J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
[TBL] [Abstract][Full Text] [Related]
20. Oral controlled release formulation for highly water-soluble drugs: drug--sodium alginate--xanthan gum--zinc acetate matrix.
Zeng WM
Drug Dev Ind Pharm; 2004 May; 30(5):491-5. PubMed ID: 15244084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
